News & Perspective

Dec 31, 2012

Dec 31, 2012

FDA approves first med for multidrug-resistant TB

(CIDRAP News) – The US Food and Drug Administration (FDA) today announced its approval of Sirturo (bedaquiline), the first drug developed specifically to treat multidrug-resistant tuberculosis (MDR-TB), saying it must be used in combination with other TB medications.

Dec 21, 2012

Dec 21, 2012

Flu pace picks up in US, Canada, parts of Europe

(CIDRAP News) – Flu activity in the Northern Hemisphere continued to climb last week, led by a vigorous pace of infections in the United States and Canada in the lead-up to the Christmas holiday season, the World Health Organization (WHO) said today.

Dec 21, 2012

WHO: Jordan cluster hints at milder coronavirus cases

(CIDRAP News) – The World Health Organization (WHO) says its recent investigation of illnesses associated with two confirmed novel coronavirus (CoV) infections in Jordan suggests that some cases can be relatively mild and that investigators are now more suspicious that the cluster involved person-to-person transmission.

Dec 18, 2012

Dec 18, 2012

Experts at NIH meeting say H5N1 research moratorium may end soon

(CIDRAP News) – As a meeting to discuss issues related to federally funded H5N1 avian influenza research wrapped up today, experts anticipated that a voluntary moratorium on work with lab-modified strains that have increased transmissibility might end soon and said they sensed agreement about lab biosecurity levels.

Dec 17, 2012

Dec 17, 2012

With more surveillance, flu patterns in Africa begin to emerge

(CIDRAP News) – Increased surveillance in recent years has begun to fill in some of the huge information gaps regarding influenza in Africa, which should eventually make it possible to develop or improve public health interventions, according to a big collection of articles published recently in the Journal of Infectious Diseases (JID).

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»